Image de couverture de livre

Research Communication: The Cumulated Spontaneous Portosystemic Shunts ( SPSS ) Area Decreases After TIPS and Impacts on Prognosis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Marlene Hintersteininger, Theresa Müllner‐Bucsics, Susanna Riegler, Nina Dominik, Georg Kramer, Christian Sebesta, Paul Thöne, Ulrika Asenbaum, Lukas Reider, Maria Schoder, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Lukas Hartl, Katharina Lampichler
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Alimentary Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death
par: Caroline Schwarz, et autres
Publié: (2025)

Reply to: Competing Risk of Mortality May Obscure the True Impact of Smoking on HCC in ACLD
par: Marlene Hintersteininger, et autres
Publié: (2025)

Effects of Shunt Position on the Prognosis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhotic Esophagogastric Variceal Bleeding
par: Yi‐Han Yang, et autres
Publié: (2025)

Transjugular Intrahepatic Portosystemic Shunt (TIPS) Promotes Wound Healing in Cirrhotic Patients With Post‐Splenectomy Complications
par: Na Han, et autres
Publié: (2025)

Prognostication of Liver Disease Patients via the WFUMB ‘Rule‐of‐4’ Algorithm Using SSI ‐ 2D ‐ SWE ‐Based Liver Stiffness Measurement
par: Christian Sebesta, et autres
Publié: (2026)

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
par: Lucie Simonis, et autres
Publié: (2025)

Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis
par: Nina Dominik, et autres
Publié: (2025)

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
par: Mathias Jachs, et autres
Publié: (2025)

The Shunting Puzzle: Congenital Portosystemic Shunts With Multisystem Manifestations
par: Maofeng Gong, et autres
Publié: (2025)

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
par: Benedikt Silvester Hofer, et autres
Publié: (2024)

Chinese Registry on Transjugular Intrahepatic Portosystemic Shunts (CN‐TIPS): Protocol for a Registry‐Based, Prospective Prognostic Study
par: Yi Xiang, et autres
Publié: (2026)

Evaluation of the Efficacy and Safety of Transjugular Intrahepatic Portosystemic Shunt Combined With Concurrent Antegrade Embolization of Large Spontaneous Portosystemic Shunts
par: Ze Wang, et autres
Publié: (2025)

A Multi‐Scale Computational Model of the Hepatic Circulation Applied to Predict the Portal Pressure After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
par: Tianqi Wang, et autres
Publié: (2025)

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
par: Nina Dominik, et autres
Publié: (2024)

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease
par: Nina Dominik, et autres
Publié: (2024)

GDF ‐15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes
par: Benedikt Silvester Hofer, et autres
Publié: (2026)

Concurrence of Circumcaval Ureter and Congenital Extrahepatic Portosystemic Shunt in a Cat
par: Bingyan Wei, et autres
Publié: (2025)

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
par: Lukas Hartl, et autres
Publié: (2024)

Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt
par: Elena Motto, et autres
Publié: (2025)

Occlusion of an Intrahepatic Portosystemic Shunt With an Amplatzer Septal Occluder Device in a Dog
par: Marion Guidat, et autres
Publié: (2026)

Expandable Constrained Transjugular Intrahepatic Portosystemic Shunt: An Individualised Approach for High‐Risk Patients?
par: Hannah Rieland, et autres
Publié: (2025)

Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
par: Lixin Song, et autres
Publié: (2025)

Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma
par: Katharina Pomej, et autres
Publié: (2024)

Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt
par: Michelle Spaan, et autres
Publié: (2025)

Neurofilament Light Chains in Serum Predict Post—Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy
par: Christian Labenz, et autres
Publié: (2025)

Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement
par: Lisa Sandmann, et autres
Publié: (2025)

The Dynamic Evolution of Lipid Profiles Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
par: Jiamin Xu, et autres
Publié: (2026)

Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure
par: Vlad Taru, et autres
Publié: (2025)

Radiomics‐Based Assessment of Portal Hypertension Severity and Risk Stratification of Cirrhotic Patients Using Routine CT Scans
par: Celine Sin, et autres
Publié: (2026)

Association Between Older Age and TIPS‐Related Hospitalization Following Shunt Placement
par: Matthew Schliep, et autres
Publié: (2025)

Probiotics Prevent Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomised Controlled Trial
par: Xin Quan, et autres
Publié: (2025)

Improvement in Irretractable Pruritus With Intrahepatic Portosystemic Shunt Embolization: From MAID to a New Lease on Life
par: Amitesh Bagha, et autres
Publié: (2026)

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
par: Lukas Burghart, et autres
Publié: (2024)

The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study
par: David J. M. Bauer, et autres
Publié: (2024)

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease
par: Benedikt Simbrunner, et autres
Publié: (2025)

An Anomalous Connection of the Left Hepatic Vein with the Coronary Sinus in a Selkirk Rex Cat with a Portosystemic Shunt
par: Juhyang Park, et autres
Publié: (2025)

Retrospective Analysis of 411 Cases of Spontaneous Portosystemic Shunt Complicated With Oesophageal and Gastric Variceal Bleeding in Cirrhotic Patients
par: Zhaoyi Chen, et autres
Publié: (2026)

Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End‐Stage Liver Disease—Authors' Reply
par: Mattias Mandorfer, et autres
Publié: (2025)

Single Posthepatic Portosystemic Shunt Communicated With Internal Thoracic Vein and Azygos Continuation of the Caudal Vena Cava in a Dog
par: Ryo Takeuchi, et autres
Publié: (2024)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
par: Lukas Burghart, et autres
Publié: (2026)